{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:53:59Z","timestamp":1793876039182,"version":"4.7.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["32170726"],"award-info":[{"award-number":["32170726"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["32100580"],"award-info":[{"award-number":["32100580"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004751","name":"Chinese Ministry of Science and Technology | Department of S and T for Social Development","doi-asserted-by":"publisher","award":["2022YFE0133400"],"award-info":[{"award-number":["2022YFE0133400"]}],"id":[{"id":"10.13039\/501100004751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-63685-8","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:51:06Z","timestamp":1759171866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cytoplasmic TRIM24 promotes colorectal cancer cell proliferation by activating Wnt\/\u03b2-catenin signaling"],"prefix":"10.1038","volume":"16","author":[{"given":"Ya","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0830-2188","authenticated-orcid":false,"given":"Shuai","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-9767","authenticated-orcid":false,"given":"Fengyi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-5352","authenticated-orcid":false,"given":"Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"63685_CR1","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cancers14071732","volume":"14","author":"MS Hossain","year":"2022","unstructured":"Hossain, M. S. et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers 14, 1732 (2022).","journal-title":"Cancers"},{"key":"63685_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"63685_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-336","volume":"14","author":"VL Tsikitis","year":"2014","unstructured":"Tsikitis, V. L., Larson, D. W., Huebner, M., Lohse, C. M. & Thompson, P. A. Predictors of recurrence free survival for patients with stage II and III colon cancer. BMC Cancer 14, 336 (2014).","journal-title":"BMC Cancer"},{"key":"63685_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol. cancer 21, 144 (2022).","journal-title":"Mol. cancer"},{"key":"63685_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-cellbio-120319-023657","volume":"37","author":"LV Albrecht","year":"2021","unstructured":"Albrecht, L. V., Tejeda-Mu\u00f1oz, N. & De Robertis, E. M. Cell biology of canonical Wnt signaling. Annu. Rev. Cell Dev. Biol. 37, 369\u2013389 (2021).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"63685_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct. Target. Ther. 7, 3 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"63685_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jcmgh.2020.04.007","volume":"10","author":"A Prossomariti","year":"2020","unstructured":"Prossomariti, A., Piazzi, G., Alquati, C. & Ricciardiello, L. Are Wnt\/\u03b2-catenin and PI3K\/AKT\/mTORC1 distinct pathways in colorectal cancer?. Cell. Mol. Gastroenterol. Hepatol. 10, 491\u2013506 (2020).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"63685_CR8","doi-asserted-by":"publisher","first-page":"110350","DOI":"10.1016\/j.cellsig.2022.110350","volume":"95","author":"S Daisy Precilla","year":"2022","unstructured":"Daisy Precilla, S., Biswas, I., Kuduvalli, S. S. & Anitha, T. S. Crosstalk between PI3K\/AKT\/mTOR and WNT\/\u03b2-Catenin signaling in GBM - Could combination therapy checkmate the collusion?. Cell. Signal. 95, 110350 (2022).","journal-title":"Cell. Signal."},{"key":"63685_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcancer.2017.12.010","volume":"56","author":"S Nagini","year":"2019","unstructured":"Nagini, S., Sophia, J. & Mishra, R. Glycogen synthase kinases: moonlighting proteins with theranostic potential in cancer. Semin. Cancer Biol. 56, 25\u201336 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"63685_CR10","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.97.7.3352","volume":"97","author":"AJ Rowan","year":"2000","unstructured":"Rowan, A. J. et al. APC mutations in sporadic colorectal tumors: a mutational \u201chotspot\u201d and interdependence of the \u201ctwo hits\u201d. Proc. Natl. Acad. Sci. USA 97, 3352\u20133357 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63685_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biochi.2018.11.003","volume":"157","author":"AS Aghabozorgi","year":"2019","unstructured":"Aghabozorgi, A. S. et al. Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and perspectives. Biochimie 157, 64\u201371 (2019).","journal-title":"Biochimie"},{"key":"63685_CR12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12029-022-00886-0","volume":"54","author":"P Bala","year":"2023","unstructured":"Bala, P., Kavadipula, P., Sarkar, S. & Bashyam, M. D. To \u03b2 or not to \u03b2: lack of correlation between APC mutation and \u03b2-catenin nuclear localization in colorectal cancer. J. Gastrointest. Cancer 54, 1181\u20131184 (2023).","journal-title":"J. Gastrointest. Cancer"},{"key":"63685_CR13","first-page":"2629","volume":"143","author":"MA Blundon","year":"2016","unstructured":"Blundon, M. A. et al. Proteomic analysis reveals APC-dependent post-translational modifications and identifies a novel regulator of \u03b2-catenin. Development 143, 2629\u20132640 (2016).","journal-title":"Development"},{"key":"63685_CR14","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3390\/cancers12082094","volume":"12","author":"RM McAvera","year":"2020","unstructured":"McAvera, R. M. & Crawford, L. J. TIF1 proteins in genome stability and cancer. Cancers 12, 2094 (2020).","journal-title":"Cancers"},{"key":"63685_CR15","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/ng.2007.15","volume":"39","author":"K Khetchoumian","year":"2007","unstructured":"Khetchoumian, K. et al. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat. Genet. 39, 1500\u20131506 (2007).","journal-title":"Nat. Genet."},{"key":"63685_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nature09542","volume":"468","author":"WW Tsai","year":"2010","unstructured":"Tsai, W. W. et al. TRIM24 links a non-canonical histone signature to breast cancer. Nature 468, 927\u2013932 (2010).","journal-title":"Nature"},{"key":"63685_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccell.2016.04.012","volume":"29","author":"AC Groner","year":"2016","unstructured":"Groner, A. C. et al. TRIM24 is an oncogenic transcriptional activator in prostate cancer. Cancer Cell. 29, 846\u2013858 (2016).","journal-title":"Cancer Cell."},{"key":"63685_CR18","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","volume":"20","author":"A Reymond","year":"2001","unstructured":"Reymond, A. et al. The tripartite motif family identifies cell compartments.  EMBO J. 20, 2140\u20132151 (2001).","journal-title":"EMBO J."},{"key":"63685_CR19","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1128\/MCB.01705-12","volume":"34","author":"AK Jain","year":"2014","unstructured":"Jain, A. K., Allton, K., Duncan, A. D. & Barton, M. C. TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage. Mol. Cell. Biol. 34, 2695\u20132709 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"63685_CR20","doi-asserted-by":"publisher","first-page":"e20192083","DOI":"10.1084\/jem.20192083","volume":"217","author":"Q Zhu","year":"2020","unstructured":"Zhu, Q. et al. TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination. J. Exp. Med. 217, e20192083 (2020).","journal-title":"J. Exp. Med."},{"key":"63685_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31735-0","volume":"13","author":"W Wei","year":"2022","unstructured":"Wei, W. et al. TRIM24 is an insulin-responsive regulator of P-bodies. Nat. Commun. 13, 3972 (2022).","journal-title":"Nat. Commun."},{"key":"63685_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","volume":"9","author":"H Xu","year":"2020","unstructured":"Xu, H., Niu, M., Yuan, X., Wu, K. & Liu, A. CD44 as a tumor biomarker and therapeutic target. Exp. Hematol. Oncol. 9, 36 (2020).","journal-title":"Exp. Hematol. Oncol."},{"key":"63685_CR23","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1182\/blood-2008-12-194290","volume":"114","author":"J Dutta-Simmons","year":"2009","unstructured":"Dutta-Simmons, J. et al. Aurora kinase A is a target of Wnt\/beta-catenin involved in multiple myeloma disease progression. Blood 114, 2699\u20132708 (2009).","journal-title":"Blood"},{"key":"63685_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s10637-009-9311-z","volume":"28","author":"PC Leow","year":"2010","unstructured":"Leow, P. C., Tian, Q., Ong, Z. Y., Yang, Z. & Ee, P. L. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt\/\u03b2-catenin antagonists against human osteosarcoma cells. Invest. New Drugs 28, 766\u2013782 (2010).","journal-title":"Invest. New Drugs"},{"key":"63685_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/ERC-13-0315","volume":"21","author":"S Sarkar","year":"2014","unstructured":"Sarkar, S., Mandal, C., Sangwan, R. & Mandal, C. Coupling G2\/M arrest to the Wnt\/\u03b2-catenin pathway restrains pancreatic adenocarcinoma. Endocr. -Relat. Cancer 21, 113\u2013125 (2014).","journal-title":"Endocr. -Relat. Cancer"},{"key":"63685_CR26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/21674","volume":"399","author":"T Ishitani","year":"1999","unstructured":"Ishitani, T. et al. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399, 798\u2013802 (1999).","journal-title":"Nature"},{"key":"63685_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13578-024-01289-3","volume":"14","author":"Y Yao","year":"2024","unstructured":"Yao, Y., Zhou, S., Yan, Y., Fu, K. & Xiao, S. The tripartite motif-containing 24 is a multifunctional player in human cancer. Cell Biosci. 14, 103 (2024).","journal-title":"Cell Biosci."},{"key":"63685_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molcel.2005.03.008","volume":"18","author":"T Gao","year":"2005","unstructured":"Gao, T., Furnari, F. & Newton, A. C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell. 18, 13\u201324 (2005).","journal-title":"Mol. Cell."},{"key":"63685_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","volume":"25","author":"J Brognard","year":"2007","unstructured":"Brognard, J., Sierecki, E., Gao, T. & Newton, A. C. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell. 25, 917\u2013931 (2007).","journal-title":"Mol. Cell."},{"key":"63685_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aad5755","volume":"353","author":"J Guo","year":"2016","unstructured":"Guo, J. et al. pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. Science 353, 929\u2013932 (2016).","journal-title":"Science"},{"key":"63685_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cell.2005.03.024","volume":"121","author":"AJ McClellan","year":"2005","unstructured":"McClellan, A. J., Scott, M. D. & Frydman, J. Folding and quality control of the VHL tumor suppressor proceed through distinct chaperone pathways. Cell 121, 739\u2013748 (2005).","journal-title":"Cell"},{"key":"63685_CR32","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1073\/pnas.93.5.1770","volume":"93","author":"S Lee","year":"1996","unstructured":"Lee, S. et al. Nuclear\/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. USA 93, 1770\u20131775 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63685_CR33","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm0895-822","volume":"1","author":"O Iliopoulos","year":"1995","unstructured":"Iliopoulos, O., Kibel, A., Gray, S. & Kaelin, W. G. Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1, 822\u2013826 (1995).","journal-title":"Nat. Med."},{"key":"63685_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41388-022-02580-8","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. TRIM24 is critical for the cellular response to DNA double-strand breaks through regulating the recruitment of MRN complex. Oncogene 42, 586\u2013600 (2023).","journal-title":"Oncogene"},{"key":"63685_CR35","doi-asserted-by":"publisher","first-page":"10171","DOI":"10.1073\/pnas.0900604106","volume":"106","author":"S Kosugi","year":"2009","unstructured":"Kosugi, S., Hasebe, M., Tomita, M. & Yanagawa, H. Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs. Proc. Natl. Acad. Sci. USA 106, 10171\u201310176 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63685_CR36","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","volume":"52","author":"M Varadi","year":"2024","unstructured":"Varadi, M. et al. AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 52, D368\u2013d375 (2024).","journal-title":"Nucleic Acids Res."},{"key":"63685_CR37","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1021\/bi0113216","volume":"41","author":"CD Andrew","year":"2002","unstructured":"Andrew, C. D., Warwicker, J., Jones, G. R. & Doig, A. J. Effect of phosphorylation on alpha-helix stability as a function of position. Biochemistry 41, 1897\u20131905 (2002).","journal-title":"Biochemistry"},{"key":"63685_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","volume":"40","author":"F Ardito","year":"2017","unstructured":"Ardito, F., Giuliani, M., Perrone, D., Troiano, G. & Lo Muzio, L. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). Int. J. Mol. Med. 40, 271\u2013280 (2017).","journal-title":"Int. J. Mol. Med."},{"key":"63685_CR39","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ccell.2021.07.006","volume":"39","author":"K Tanaka","year":"2021","unstructured":"Tanaka, K. et al. Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis. Cancer Cell. 39, 1245\u20131261.e1246 (2021).","journal-title":"Cancer Cell."},{"key":"63685_CR40","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1038\/s41388-022-02328-4","volume":"41","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Hesperadin suppresses pancreatic cancer through ATF4\/GADD45A axis at nanomolar concentrations. Oncogene 41, 3394\u20133408 (2022).","journal-title":"Oncogene"},{"key":"63685_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biochi.2022.01.009","volume":"195","author":"C Disoma","year":"2022","unstructured":"Disoma, C., Zhou, Y., Li, S., Peng, J. & Xia, Z. Wnt\/\u03b2-catenin signaling in colorectal cancer: is therapeutic targeting even possible?. Biochimie 195, 39\u201353 (2022).","journal-title":"Biochimie"},{"key":"63685_CR42","first-page":"101","volume":"13","author":"EM Schatoff","year":"2017","unstructured":"Schatoff, E. M., Leach, B. I. & Dow, L. E. Wnt signaling and colorectal cancer. Curr. Colorectal Cancer Rep. 13, 101\u2013110 (2017).","journal-title":"Curr. Colorectal Cancer Rep."},{"key":"63685_CR43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/onc.2013.593","volume":"34","author":"LH Zhang","year":"2015","unstructured":"Zhang, L. H. et al. TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K\/Akt signaling pathway. Oncogene 34, 600\u2013610 (2015).","journal-title":"Oncogene"},{"key":"63685_CR44","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1002\/cam4.3310","volume":"9","author":"W Xie","year":"2020","unstructured":"Xie, W. et al. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling. Cancer Med. 9, 6367\u20136376 (2020).","journal-title":"Cancer Med."},{"key":"63685_CR45","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.1073\/pnas.0813177106","volume":"106","author":"K Allton","year":"2009","unstructured":"Allton, K. et al. Trim24 targets endogenous p53 for degradation. Proc. Natl. Acad. Sci. USA 106, 11612\u201311616 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63685_CR46","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3892\/ol.2017.5604","volume":"13","author":"Z Fang","year":"2017","unstructured":"Fang, Z. et al. TRIM24 promotes the aggression of gastric cancer via the Wnt\/\u03b2-catenin signaling pathway. Oncol. Lett. 13, 1797\u20131806 (2017).","journal-title":"Oncol. Lett."},{"key":"63685_CR47","first-page":"831","volume":"14","author":"H Tian","year":"2022","unstructured":"Tian, H. et al. TRIM24 promotes colorectal cancer cell progression via the Wnt\/\u03b2-catenin signaling pathway activation. Am. J. Transl. Res. 14, 831\u2013848 (2022).","journal-title":"Am. J. Transl. Res."},{"key":"63685_CR48","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/jpm12060991","volume":"12","author":"L Klapper","year":"2022","unstructured":"Klapper, L. et al. TRIM24 expression as an independent biomarker for prognosis and tumor recurrence in HNSCC. J. Pers. Med. 12, 991 (2022).","journal-title":"J. Pers. Med."},{"key":"63685_CR49","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.bbamcr.2009.11.001","volume":"1793","author":"M Kikuchi","year":"2009","unstructured":"Kikuchi, M. et al. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. Biochim. Biophys. Acta 1793, 1828\u20131836 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"63685_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55\u201362 (2016).","journal-title":"Nature"},{"key":"63685_CR51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jprot.2013.07.023","volume":"91","author":"DK Schweppe","year":"2013","unstructured":"Schweppe, D. K., Rigas, J. R. & Gerber, S. A. Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J. Proteom. 91, 286\u2013296 (2013).","journal-title":"J. Proteom."},{"key":"63685_CR52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/2159-8290.CD-21-0912","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Bacterial genotoxin accelerates transient infection-driven murine colon tumorigenesis. Cancer Discov. 12, 236\u2013249 (2022).","journal-title":"Cancer Discov."},{"key":"63685_CR53","doi-asserted-by":"publisher","first-page":"e21957","DOI":"10.7554\/eLife.21957","volume":"5","author":"K Fu","year":"2016","unstructured":"Fu, K. et al. Sam68\/KHDRBS1-dependent NF-kappaB activation confers radioprotection to the colon epithelium in gamma-irradiated mice. Elife 5, e21957 (2016).","journal-title":"Elife"},{"key":"63685_CR54","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"63685_CR55","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357, eaan2507 (2017).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63685-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63685-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63685-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:04:28Z","timestamp":1759172668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63685-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63685"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63685-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8598"}}